Posted on 9/18/20
ProPhase Labs Announces $10 Million Unsecured Debt Financing
DOYLESTOWN, Pennsylvania, Sept. 18, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced that it has closed on a $10 million unsecured debt . . .
Posted on 9/18/20
New York Files Charges Against Johnson & Johnson Over Opioid Marketing
New York's Department of Financial Services filed civil charges against Johnson & Johnson (NYSE:JNJ) on Thursday, accusing the biopharmaceutical giant of downplaying the risks to patients . . .
Posted on 9/17/20
Cantel Medical Reports Results for its Fourth Quarter Fiscal Year 2020
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2020.Fourth quarter 2020 net sales were $233.4M, down 2.5% compared . . .
Posted on 9/17/20
Papyrus Therapeutics Collaborates With Oxford Biomedica
WEST CHESTER, Pa.--(BUSINESS WIRE)--Papyrus Therapeutics, Inc., an emerging biopharma company developing novel extracellular tumor suppressor therapies for the treatment of cancer and Oxford Biomedica plc (LSE:OXB), . . .
Posted on 9/17/20
Johnson & Johnson: For The Very Young To The Very Old
SummaryFor established businesses, dividends and earnings per share (EPS) growth are the primary drivers of total returns on share investments.P/E ratios, or more specifically, changes in . . .
Posted on 9/20/20
Melina Sánchez Montañés, Impact First Investments, Interview with Irad Eichler, CEO at 7Chairs
Irad Eichler is a social entrepreneur who co-founded 7Chairs in 2019. 7Chairs is a teletherapy startup focused on providing emotional support to everyone who is dealing with . . .
Posted on 9/16/20
Should You Buy Gilead Now That It's Acquiring Immunomedics?
Many investors have long hoped that Gilead Sciences (NASDAQ:GILD) would use its massive cash stockpile to fund a major acquisition. That hope is now being fulfilled.Gilead . . .
Posted on 9/16/20
Germany Awards $743 Million to BioNTech and CureVac for Coronavirus Vaccine Development
To accelerate COVID-19 vaccine development and boost vaccine manufacturing capacity within its borders, the German Federal Ministry of Education and Research is awarding BioNTech (NASDAQ:BNTX) and . . .
Posted on 9/15/20
Tridiuum Named Healthcare Innovator of the Year by the Philadelphia Alliance for Capital and Technologies
Tridiuum, the nation's premier provider of digital behavioral health solutions, today announced it has been named Healthcare Innovator of the Year by the Philadelphia Alliance for . . .
Posted on 9/15/20
VerdePharmHealth Partnership with Altopa
NEW HOPE, Pa.--(BUSINESS WIRE)--VerdePharmHealth today announced the signing of an exclusive national group purchasing agreement with Altopa, creator of the Oblend, a patented device and technology . . .
Posted on 9/15/20
Imagine Health Partnership with University of Pennsylvania Health System
PHILADELPHIA & COTTONWOOD HEIGHTS, Utah--(BUSINESS WIRE)--Imagine Health announced today it has broadened its partnership with the University of Pennsylvania Health System to improve access to affordable, world-class . . .
Posted on 9/15/20
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Mylan (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the companies have received final approval from the European Commission (EC) for the proposed combination . . .
Posted on 9/15/20
Johnson & Johnson: Pick It In The Absence Of News
SummaryQ2 is seen by company's management as the worst quarter as the things started to improve at the end of the quarter.COVID-19 vaccine is planned to . . .
Posted on 9/15/20
Pfizer Says It Could Know If Its COVID-19 Vaccine Candidate Works in October
Pfizer (NYSE:PFE) is conducting one of the most advanced trials of a vaccine for COVID-19, and CEO Albert Bourla told an interviewer on Sunday that the . . .
Posted on 9/15/20
Merck Inks Multibillion-Dollar Deal With Seattle Genetics, Including Equity
Merck & Co (NYSE:MRK) and Seattle Genetics (NASDAQ:SGEN) have agreed to terms in a licensing and equity-investment deal that could be worth $4.2 billion to Seattle . . .
Posted on 9/14/20
Johnson & Johnson: Pick It In The Absence Of News
SummaryQ2 is seen by company's management as the worst quarter as the things started to improve at the end of the quarter.COVID-19 vaccine is planned to . . .
Posted on 9/14/20
2020’s States that Vaccinate the Most – WalletHub Study
With multiple companies racing to develop an effective COVID-19 vaccine but 1 in 3 Americans saying they wouldn’t get vaccinated, the personal-finance website WalletHub today released . . .
Posted on 9/14/20
Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical Trial
Within the next week, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) expect to reach their goal of enrolling 30,000 participants in the phase 2/3 clinical trial testing their . . .
Posted on 9/14/20
Merck (Finally) Starts a Clinical Trial of its Coronavirus Vaccine
Multiple drugmakers are in phase 3 clinical trials for their coronavirus vaccines -- the last stage before potential approval. Meanwhile, Merck (NYSE:MRK) is just now starting . . .
Posted on 9/14/20
Gilead Sciences to Acquire Immunomedics for $21 Billion in Cash
Gilead Sciences' (NASDAQ:GILD) mission to create a better oncology portfolio took a big step forward on Sunday. The company best known for antiviral treatments made Immunomedics . . .
Posted on 9/13/20
Strongbridge Biopharma Provides Corporate Update
DUBLIN, Ireland and TREVOSE, Pa., (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies . . .
Posted on 9/11/20
Pfizer's Latest Stealthy Move Could Help It Win the Coronavirus Vaccine Race
Pfizer (NYSE:PFE) hasn't been bashful about playing up the prospects for its coronavirus vaccine candidate, BNT162b2, co-developed with BioNTech (NASDAQ:BNTX). The company even predicted that it . . .
Posted on 9/10/20
Universal Health Services Prices Senior Secured Notes Offering
Universal Health Services, Inc. (NYSE: UHS) today announced the pricing of its previously announced private offering of senior secured notes due 2030. The Company priced the . . .
Posted on 9/10/20
Universal Health Services Announces Offering Of Senior
Universal Health Services, Inc. (NYSE: UHS) today announced an offering of senior secured notes due 2030. The Company intends to use the net proceeds of the . . .
Posted on 9/10/20
Is Pfizer the Best Way to Play the Coronavirus Vaccine Race?
Nucleic acid vaccines, which are either DNA- or RNA-based, hold significant promise in the fight against COVID-19. Pharma giant Pfizer (NYSE:PFE) and clinical-stage Moderna (NASDAQ:MRNA) are . . .
Philadelphia
